693 Alberta AHCIP code: Dermatitis due to substances taken internally

693 is the Alberta diagnostic code for “Dermatitis due to substances taken internally” in Alberta Health’s January 2018 release, in effect from Jan 18, 2018.

Official description

693

Dermatitis due to substances taken internally

Alberta AHCIP diagnostic codes (ICD-9) · Alberta

More specific than 693

693 is a valid code on its own. When the note says more, one of these may fit better.

Notes for 693

As Alberta Health prints them, with any note 693 takes from the headings above it.

Excludes

Conditions classified elsewhere.

Where 693 sits

  1. 1ChapterXII. Diseases of the skin and subcutaneous tissue
  2. 2Block 690-698Other inflammatory conditions of skin and subcutaneous tissue
  3. 3Valid code 693Dermatitis due to substances taken internally

Source and release

Data release
Alberta AHCIP · January 2018
Effective date
Jan 18, 2018

This page is built from the Alberta AHCIP catalog that Vero Codes reads when it suggests codes: Alberta Health’s January 2018 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does Alberta diagnostic code 693 mean?

693 is the Alberta diagnostic code for “Dermatitis due to substances taken internally” in Alberta Health’s Alberta AHCIP January 2018 release.

Where is 693 in Alberta AHCIP?

693 sits under 690-698 Other inflammatory conditions of skin and subcutaneous tissue, within XII. Diseases of the skin and subcutaneous tissue.

What coding notes apply to 693?

Alberta AHCIP lists Excludes notes for 693, including those from the headings it sits under. They are listed on this page with where each one comes from.

Which Alberta AHCIP release does this page use?

It uses Alberta Health’s January 2018 release, in effect from Jan 18, 2018. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.